Referenties Geheugen

  1. Sims, R., Van Der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., ... & Martin, E. R. (2017). Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature genetics, 49 (9), 1373.
  2. Libro, R., Diomede, F., Scionti, D., Piattelli, A., Grassi, G., Pollastro, F., ... & Trubiani, O. (2016). Cannabidiol modulates the expression of Alzheimer’s disease-related genes in mesenchymal stem cells. International journal of molecular sciences, 18 (1), 26.
  3. Kukull, W. A., & Bowen, J. D. (2002). Dementia epidemiology. The Medical clinics of North America, 86 (3), 573-590.
  4. Rondeau, V., Commenges, D., Jacqmin-Gadda, H., & Dartigues, J. F. (2000). Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. American Journal of Epidemiology, 152 (1), 59-66.
  5. Jacqmin-Gadda, H., Commenges, D., Letenneur, L., & Dartigues, J. F. (1996). Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology, 281-285.
  6. Gillette-Guyonnet, S., Andrieu, S., & Vellas, B. (2007). The potential influence of silica present in drinking water on Alzheimer's disease and associated disorders. The journal of nutrition, health & aging, 11 (2), 119.
  7. House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004). Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ 42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. Journal of Alzheimer's Disease, 6 (3), 291-301.
  8. Olasehinde, T. A., Olaniran, A. O., & Okoh, A. I. (2017). Therapeutic potentials of microalgae in the treatment of Alzheimer’s disease. Molecules, 22 (3), 480.
  9. Lau, B. W. M., Chia-Di Lee, J., Li, Y., Fung, S. M. Y., Sang, Y. H., Shen, J., ... & So, K. F. (2012). Polysaccharides from wolfberry prevents corticosterone-induced inhibition of sexual behavior and increases neurogenesis. PLoS One, 7 (4), e33374.
  10. Zainuddin, M. S. A., & Thuret, S. (2012). Nutrition, adult hippocampal neurogenesis and mental health. British medical bulletin, 103 (1), 89.
  11. Spencer, N. J., Hibberd, T. J., Travis, L., Wiklendt, L., Costa, M., Hu, H., ... & Sorensen, J. (2018). Identification of a rhythmic firing pattern in the enteric nervous system that generates rhythmic electrical activity in smooth muscle. Journal of Neuroscience, 3489-17.
  12. Park, H. R., & Lee, J. (2011). Neurogenic contributions made by dietary regulation to hippocampal neurogenesis. Annals of the New York Academy of Sciences, 1229 (1), 23-28.
  13. de la Monte, S. M., & Wands, J. R. (2008). Alzheimer's disease is type 3 diabetes—evidence reviewed. Journal of diabetes science and technology, 2 (6), 1101-1113.
  14. Daulatzai, M. A. (2016). Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer’s disease. American journal of neurodegenerative disease, 5 (1), 1.
  15. Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., ... & Wolf, P. A. (2006). Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Archives of neurology, 63 (11), 1545-1550.
  16. McCann, J. C., Hudes, M., & Ames, B. N. (2006). An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring. Neuroscience & Biobehavioral Reviews, 30 (5), 696-712.
  17. Grieb, P. (2015). Citicoline: a food that may improve memory. Med. Sci. Rev, 2, 67-72.
  18. Hirayama, S., Terasawa, K., Rabeler, R., Hirayama, T., Inoue, T., Tatsumi, Y., ... & Jäger, R. (2014). The effect of phosphatidylserine administration on memory and symptoms of attention‐deficit hyperactivity disorder: a randomised, double‐blind, placebo‐controlled clinical trial. Journal of human nutrition and dietetics, 27, 284-291.
  19. Vakhapova, V., Cohen, T., Richter, Y., Herzog, Y., Kam, Y., & Korczyn, A. D. (2014). Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study. Dementia and geriatric cognitive disorders, 38 (1-2), 39-45.
  20. Williams, J., Kellett, J., Roach, P. D., McKune, A., Mellor, D., Thomas, J., & Naumovski, N. (2016). L-theanine as a functional food additive: Its role in disease prevention and health promotion. Beverages, 2 (2), 13.
  21. Stough, C., Downey, L. A., Lloyd, J., Silber, B., Redman, S., Hutchison, C., ... & Nathan, P. J. (2008). Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double‐blind placebo‐controlled randomized trial. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 22 (12), 1629-1634.
  22. Calabrese, C., Gregory, W. L., Leo, M., Kraemer, D., Bone, K., & Oken, B. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. The journal of alternative and complementary medicine, 14 (6), 707-713.
  23. Stough, C., Lloyd, J., Clarke, J., Downey, L., Hutchison, C., Rodgers, T., & Nathan, P. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 156 (4), 481-484.
  24. Aguiar, S., & Borowski, T. (2013). Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation research, 16 (4), 313-326.
  25. Calabrese, C., Gregory, W. L., Leo, M., Kraemer, D., Bone, K., & Oken, B. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. The journal of alternative and complementary medicine, 14 (6), 707-713.
  26. Singh, H. K., & Dhawan, B. N. (1982). Effect of Bacopa monniera Linn.(Brāhmi) extract on avoidance responses in rat. Journal of ethnopharmacology, 5 (2), 205-214.
  27. Williams, J., Kellett, J., Roach, P. D., McKune, A., Mellor, D., Thomas, J., & Naumovski, N. (2016). L-theanine as a functional food additive: Its role in disease prevention and health promotion. Beverages, 2 (2), 13.
  28. Larson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., Crane, P., & Kukull, W. (2006). Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Annals of internal medicine, 144 (2), 73-81.
  29. Klaus, F., & Amrein, I. (2012). Running in laboratory and wild rodents: differences in context sensitivity and plasticity of hippocampal neurogenesis. Behavioural brain research, 227 (2), 363-370.
  30. Jacqmin-Gadda, H., Commenges, D., Letenneur, L., & Dartigues, J. F. (1996). Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology, 281-285.
  31. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003). Alzheimer disease in the US population: prevalence estimates using the 2000 census. Archives of neurology, 60 (8), 1119-1122.
  32. Sies, H., Stahl, W., & Sevanian, A. (2005). Nutritional, dietary and postprandial oxidative stress. The Journal of nutrition, 135 (5), 969-972.
  33. Lindsay, J., Laurin, D., Verreault, R., Hébert, R., Helliwell, B., Hill, G. B., & McDowell, I. (2002). Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. American journal of epidemiology, 156 (5), 445-453.